Behavioral counseling and varenicline treatment for smoking cessation.

ABSTRACT:

Background

Smoking remains the primary preventable cause of death and illness in the U.S. Effective, convenient treatment programs are needed to reduce smoking prevalence.

Purpose

This study compared the effectiveness of three modalities of a behavioral smoking-cessation program in smokers using varenicline.

Methods

Current treatment-seeking smokers (n=1202) were recruited from a large healthcare organization between October 2006 and October 2007. Eligible participants were randomized to one of three smoking-cessation interventions: web-based counseling (n=401); proactive telephone-based counseling (PTC; n=402); or combined PTC and web counseling (n=399). All participants received a standard 12-week FDA-approved course of varenicline. Self-report determined the primar

SUBMITTER: Swan GE 

PROVIDER: S-EPMC2879135 | biostudies-literature | 2010 May

REPOSITORIES: biostudies-literature